全球兽医治疗与诊断市场
市场调查报告书
商品编码
1382553

全球兽医治疗与诊断市场

Global Markets for Animal Therapeutics and Diagnostics

出版日期: | 出版商: BCC Research | 英文 303 Pages | 订单完成后即时交付

价格

全球兽医治疗和诊断市场规模预计将从 2023 年的 610 亿美元成长到 2028 年的 812 亿美元,预测期内年复合成长率为 5.9%。

製药部门预计将从2023年的246亿美元成长到2028年的333亿美元,同期年复合成长率为6.2%。此外,饲料添加剂部门预计将从2023年的216亿美元成长到2028年的275亿美元,年复合成长率为5.0%。

本报告调查了全球兽医治疗和诊断市场,提供了市场背景和概述、市场影响因素和市场机会分析、法律制度、市场规模趋势和预测,以及按各个细分市场和地区进行的细分。它总结了详细的分析,技术与专利动态、ESG动态、竞争形势、主要企业概况等。

目录

第1章简介

第2章总结/要点

  • 市场展望
  • 市场总结
  • 推动动物保健产业的趋势

第3章市场概况

  • 动物解剖学和生理学
  • 生殖系统
  • 鸟类解剖学
  • 美国动物数量
  • 伴侣动物
  • 食用动物
  • 肉类消费量
  • 按国家分類的动物数量

第4章市场动态

  • 市场动态
  • 市场驱动因素
  • 市场抑制因素
  • 机会
  • 法规状况
  • Food and Drug Administration (FDA)
  • 欧洲药品管理局 (EMA)・兽用药品委员会 (CVMP)
  • Australian Pesticides and Veterinary Medicines Authority (APVMA)
  • 巴西农业、畜牧业和供应部 (MAPA)
  • 生产动物的抗生素使用和抗药性
  • FDA 抗菌限制
  • 美国受污染肉类的水平
  • 减重畜牧生产中抗生素使用的运动
  • 最低限度和高度法规的产品
  • 2003 年动物药物使用者收费法
  • 2008 年《动物药物使用者收费法》修正案 (ADUFA II)
  • 2013 年《动物药物使用者收费法》修正案 (ADUFA III)
  • 2018 年《动物药物使用者收费法》修正案 (ADUFA III)

第5章全球动物治疗与诊断市场

  • 概述
  • 市场规模

第6章全球动物疫苗市场

  • 概述
  • 产品概要
  • 主动免疫
  • 被动免疫
  • 其他类型
  • 伴侣动物
  • 病毒
  • 伴侣动物疫苗
  • 伴侣动物疫苗市场的主要企业
  • 疫苗提供者
  • 生产动物
  • 病毒和朊病毒
  • 动物疫苗生产
  • 动物疫苗市场的主要企业

第7章全球兽药市场

  • 概述
  • 老兵专用医药
  • 伴侣动物市场和生产动物市场
  • 按地区分類的动物药品市场
  • 过敏和呼吸系统药物
  • 伴侣动物:过敏和发炎疾病
  • 兽医过敏和呼吸系统药物市场的主要企业
  • 兽医过敏和呼吸系统药物
  • 感染疾病
  • 伴侣动物:细菌感染疾病
  • 生产动物:细菌感染疾病
  • 兽药市场的主要企业
  • 动物感染疾病
  • 发炎药/止痛药
  • 动物发炎镇痛药市场的主要企业
  • 动物发炎镇痛药
  • 治疗代谢和内分泌疾病的药物
  • 代谢及内分泌疾病
  • 动物代谢和内分泌市场的主要企业
  • 动物代谢药物
  • 寄生剂
  • 伴侣动物:寄生虫病
  • 生产动物:寄生虫病的例子
  • 动物杀虫剂市场的主要企业
  • 动物杀寄生虫剂
  • 精神药物
  • 动物精神药物市场的主要企业
  • 自然疗法
  • 动物精神药物
  • 其他药品
  • 伴侣动物 - 其他疾病
  • 动物药品市场的其他主要企业
  • 牙科
  • 其他兽药

第8章全球饲料添加剂市场

  • 概述
  • 饲料添加剂
  • 伴侣动物和生产动物市场规模
  • 饲料添加剂市场区域分布
  • 饲料添加剂市场的主要企业
  • 胺基酸
  • 动物性胺基酸市场的主要企业
  • 动物性胺基酸
  • 医药添加物
  • 动物药用辅料市场的主要企业
  • 药用饲料添加剂
  • 营养补充食品
  • 动物营养补充食品的主要企业
  • 营养补充食品分析
  • 维生素和矿物质
  • 动物维生素和矿物质市场的主要企业
  • 动物维生素和矿物质

第9章全球动物诊断市场

  • 概述
  • 动物诊断
  • 伴侣动物市场和生产动物市场
  • 按地区分類的动物诊断市场
  • 诊断测试:概述
  • 集中式和分散式临床测试
  • 诊断影像
  • 动物诊断市场的主要企业
  • 动物诊断市场:副产品
  • 快速诊断测试
  • 诊断分析仪及消耗品
  • 影像诊断设备

第10章全球动物治疗与诊断市场:按地区

  • 北美洲
  • 欧洲
  • 亚太地区
  • 其他地区

第11章ESG发展

  • ESG概述
  • ESG 在动物治疗和诊断行业的重要性
  • 动物治疗和诊断行业的关键 ESG 问题
  • ESG 评级和指标:了解资料
  • 动物治疗与诊断产业的 ESG 实践
  • 未来的趋势
  • BCC 的观点

第12章併购/资金筹措分析

  • 併购分析
  • 资助动物保健产业

第13章竞争资讯

  • 2022年主要企业
  • 企业的关键招募策略
  • M&A
  • 新产品发布
  • 合伙
  • 核准
  • 其他的

第14章公司简介

  • ARKO LABORATORIES
  • AVIMEX
  • BOEHRINGER INGELHEIM INTERNATIONAL GMBH
  • CEVA SANTE ANIMALE (CEVA)
  • DECHRA PHARMACEUTICALS PLC
  • DSM NUTRITIONAL PRODUCTS
  • ELANCO ANIMAL HEALTH INC.
  • MERCK & CO. INC.
  • PHIBRO ANIMAL HEALTH CORP.
  • VIRBAC SA
  • ZOETIS INC.
Product Code: HLC034G

Highlights:

The global market for animal therapeutics and diagnostics is estimated to increase from $61.0 billion in 2023 to reach $81.2 billion by 2028, at a compound annual growth rate (CAGR) of 5.9% from 2023 through 2028.

The global market for animal therapeutics and diagnostics for pharmaceuticals segment is estimated to increase from $24.6 billion in 2023 to reach $33.3 billion by 2028, at a compound annual growth rate (CAGR) of 6.2% from 2023 through 2028.

The global market for animal therapeutics and diagnostics for feed additives segment is estimated to increase from $21.6 billion in 2023 to reach $27.5 billion by 2028, at a compound annual growth rate (CAGR) of 5.0% from 2023 through 2028.

##img_0##

Report Scope:

The report's scope includes an overview of the global market for animal therapeutics and diagnostics along with an analysis of global market trends; the report uses 2022 as the base year and forecasts 2023 the compound annual growth rate (CAGR) for 2023 to 2028.

The report is designed to be a helpful business tool that will provide a thorough evaluation of the animal therapeutics and diagnostics market. The geographical scope of this study is worldwide, with special interest for markets, trends, and statistics by key geographical regions such as the United States, European countries, and Brazil, Japan, and Australia. The report identifies markets in four segments: vaccines, pharmaceuticals, feed additives, and diagnostics. For the purpose of this study, diagnostics include products that are used at the point of care and are considered rapid tests or kits, in-clinic analyzers, and imaging equipment. Each market segment provides detailed information based on product categories, use of products, forecasts, and competitive analyses.

Report Includes:

  • 56 data tables and 143 additional tables
  • An overview of the global market for animal therapeutics and diagnostics
  • Estimates of the market size and analyses of global market trends with data from 2020-2023, and projections of compound annual growth rates (CAGRs) through 2028
  • Assessment of market drivers, opportunities, and restraints, and current trends and technological advances
  • Evaluation of the market with a focus of global production of animal healthcare products, vaccines, feed additives, therapeutic and diagnostic drugs
  • Analyses of the market shares of the leading suppliers of animal vaccines and therapeutic drugs, the competitive landscape, market positioning, revenue sales and product segments
  • Discussion of the role of major providers of vaccines and companion animal products approved for a wide variety of indications, and emerging technologies in the market.
  • Analyses of ESG trends and patents granted for animal health products
  • Profiles of the leading companies, including Boehringer Ingelheim, DSM Nutritional Products, Merck & Co. Inc., Phibro Animal Health Corp., Virbac S.A., and Zoetis Services LLC

Table of Contents

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • What's New in this Report
  • Research Methodology
  • Information Sources
  • Geographic Breakdown
  • Segmentation Breakdown

Chapter 2 Summary and Highlights

  • Market Outlook
  • Market Summary
  • Trends Driving the Animal Health Industry

Chapter 3 Market Overview

  • Animal Anatomy and Physiology
  • Reproductive System
  • Avian Anatomy
  • Animal Populations in the United States
  • Companion Animals
  • Food Production Animals
  • Meat Consumption
  • Animal Populations by Country

Chapter 4 Market Dynamics

  • Market Dynamics
  • Drivers
  • Market Restraints
  • Opportunities
  • Regulatory Landscape
  • Food and Drug Administration (FDA)
  • European Medicines Agency (EMA) and Committee for Medicinal Products for Veterinary Use (CVMP)
  • Australian Pesticides and Veterinary Medicines Authority (APVMA)
  • The Ministry of Agriculture, Livestock and Supply (MAPA) of Brazil
  • Antibiotic Use and Resistance in Production Animals
  • FDA's Antimicrobial Restrictions
  • Levels of Contaminated Meats in the U.S.
  • Movement for Lower Amounts of Antibiotics in Livestock Production
  • Minimally and Highly Regulated Products
  • Animal Drug User Fee Act of 2003
  • Animal Drug User Fee Amendments of 2008 (ADUFA II)
  • Animal Drug User Fee Amendments of 2013 (ADUFA III)
  • Animal Drug User Fee Amendments of 2018 (ADUFA III)

Chapter 5 Global Market for Animal Therapeutics and Diagnostics

  • Overview
  • Market Size

Chapter 6 Global Market for Animal Vaccines

  • Overview
  • Product Introduction
  • Active Immunity
  • Passive Immunity
  • Other Types
  • Companion Animals
  • Viruses
  • Companion Animal Vaccines
  • Major Players in the Market for Companion Animal Vaccines
  • Vaccine Providers
  • Production Animals
  • Viruses and Prions
  • Production Animal Vaccines
  • Major Players in the Market for Production Animal Vaccines

Chapter 7 Global Market for Animal Pharmaceuticals

  • Overview
  • Animal Pharmaceuticals
  • Companion Animal vs. Production Animal Markets
  • Animal Pharmaceuticals Market by Region
  • Allergy and Respiratory Drugs
  • Companion Animals: Allergy and Inflammatory Diseases
  • Major Players in the Market for Animal Allergy and Respiratory Drugs
  • Animal Allergy and Respiratory Drugs
  • Anti-infectives
  • Companion Animals-Bacterial Infections
  • Production Animals-Bacterial Infections
  • Major Players in the Market for Animal Drugs
  • Animal Anti-infectives
  • Anti-inflammatories and Analgesics
  • Major Players in the Market for Animal Anti-Inflammatory and Analgesic Drugs
  • Animal Anti-Inflammatory and Analgesic Drugs
  • Metabolic and Endocrine Disorder Drugs
  • Metabolic Diseases and Endocrine Disorders
  • Major Players in the Market for Animal Metabolic and Endocrines
  • Animal Metabolic Drugs
  • Parasiticides
  • Companion Animals-Parasitic Diseases
  • Production Animals-Parasitic Disease Example
  • Major Players in the Market for Animal Parasiticides
  • Animal Parasiticides
  • Psychotropic Medications
  • Major Players in the Market for Animal Psychotropic Medications
  • Natural Remedies
  • Animal Psychotropic Medications
  • Other Pharmaceuticals
  • Companion Animals-Other Diseases
  • Major Players in Market for Other Animal Pharmaceuticals
  • Dental
  • Other Animal Pharmaceuticals

Chapter 8 Global Market for Animal Feed Additives

  • Overview
  • Animal Feed Additives
  • Companion Animal vs. Production Animal Market Size
  • Market for Animal Feed Additives by Region
  • Major Players in the Market for Animal Feed Additives
  • Amino Acids
  • Major Players in the Market for Amino Acids for Animals
  • Amino Acids for Animals
  • Medicinal Additives
  • Major Players in the Market for Medicinal Additives for Animals
  • Medicinal Feed Additives
  • Nutritional Supplements
  • Major Players in the Market for Animal Nutritional Supplements
  • Nutritional Supplement Market Analysis
  • Vitamins and Minerals
  • Major Players in the Market for Vitamins and Minerals for Animals
  • Vitamins and Minerals for Animals

Chapter 9 Global Market for Animal Diagnostics

  • Overview
  • Animal Diagnostics
  • Companion Animal vs. Production Animal Markets
  • Market for Animal Diagnostics by Region
  • Diagnostic Test Descriptions
  • Centralized and Decentralized Laboratory Tests
  • Diagnostic Imaging
  • Major Players in the Market for Animal Diagnostics
  • Market for Animal Diagnostics by Product
  • Diagnostic Rapid Testing
  • Diagnostic Analyzers and Consumables
  • Diagnostic Imaging Equipment

Chapter 10 Global Market for Animal Therapeutics and Diagnostics by Region

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Chapter 11 ESG Developments

  • Introduction to ESG
  • Importance of ESG in the Animal Therapeutics and Diagnostics Industry
  • Key ESG Issues in the Animal Therapeutics and Diagnostics Industry
  • ESG Ratings and Metrics: Understanding the Data
  • ESG Practices in the Animal Therapeutics and Diagnostics Industry
  • Future Trends
  • BCC Research Viewpoint

Chapter 12 M&A and Funding Analysis

  • M&A Analysis
  • Funding in the Animal Healthcare Industry

Chapter 13 Competitive Intelligence

  • Top Market Players 2022
  • Key Strategies Adopted by Companies
  • Mergers & Acquisitions
  • New Product Launches
  • Partnerships
  • Approvals
  • Others

Chapter 14 Company Profiles

  • ARKO LABORATORIES
  • AVIMEX
  • BOEHRINGER INGELHEIM INTERNATIONAL GMBH
  • CEVA SANTE ANIMALE (CEVA)
  • DECHRA PHARMACEUTICALS PLC
  • DSM NUTRITIONAL PRODUCTS
  • ELANCO ANIMAL HEALTH INC.
  • MERCK & CO. INC.
  • PHIBRO ANIMAL HEALTH CORP.
  • VIRBAC S.A.
  • ZOETIS INC.

List of Tables

  • Summary Table : Global Market for Animal Therapeutics and Diagnostics, by Product Type, Through 2028
  • Table 1 : Gestation Periods of Selected Common Species
  • Table 2 : Lifespan of Common Species of Birds
  • Table 3 : Population of Food Production Animals in the United States, 2022
  • Table 4 : Top Broiler-Producing States in the U.S., 2021
  • Table 5 : Commercial Red Meat Production in the U.S., April 2022
  • Table 6 : Beef and Veal Consumption, by Country, Through 2025
  • Table 7 : Pork Consumption, by Country, Through 2025
  • Table 8 : Poultry Consumption, by Country, Through 2025
  • Table 9 : Lamb/Mutton Consumption, by Country, Through 2025
  • Table 10 : Dog Ownership, by Select Country, 2023
  • Table 11 : Cat Ownership, by Select Country, 2021
  • Table 12 : Horse (Equine) Population, by Country, 2023
  • Table 13 : Cattle (Bovine) Population, by Country, 2023
  • Table 14 : Pig/Hog (Swine) Population, by Country, 2021
  • Table 15 : Sheep Population, by Country, 2023
  • Table 16 : Goat Population, by Country, 2021
  • Table 17 : Chicken Meat Production, by Country, 2022
  • Table 18 : Market Dynamics: Impact Analysis
  • Table 19 : Number of Outbreaks, Cases and Animal Losses Caused by ASF, 2021
  • Table 20 : States with the Highest Employment Level in Veterinary Assistants and Laboratory Animal Caretakers, May 2022
  • Table 21 : Estimated Number of U.S. Private Veterinary Practices, by Type of Practice, 2021 and 2022
  • Table 22 : Basic Annual Spending on Pets in the U.S., APPA National Pet Owners Survey, 2022
  • Table 23 : Pet Insurance Plan Comparisons in the United States
  • Table 24 : Common Examples of Zoonotic Diseases
  • Table 25 : Affected Pioneer, Generic and Combination Antimicrobials Used in the U.S. Food-Producing Animals (Updated April 1, 2019)
  • Table 26 : Global Market for Animal Therapeutics and Diagnostics, by Product Segment, Through 2028
  • Table 27 : Global Market for Animal Therapeutics and Diagnostics, by Animal Group, Through 2028
  • Table 28 : Global Market for Animal Therapeutics and Diagnostics, by Region, Through 2028
  • Table 29 : Global Market for Animal Vaccines, by Animal Group, Through 2028
  • Table 30 : Global Market for Animal Vaccines, by Region, Through 2028
  • Table 31 : Global Market for Companion Animal Vaccines, by Animal Species, Through 2028
  • Table 32 : Boehringer Ingelheim's Companion Animal Vaccines, by Target Species
  • Table 33 : Elanco's Companion Animal Vaccines, by Target Species
  • Table 34 : Merck's Companion Animal Vaccines, by Target Species
  • Table 35 : Zoetis' Companion Animal Vaccines, by Target Species
  • Table 36 : CSF-Free Countries, OIE Member Countries, as of May 2023
  • Table 37 : Global Market for Production Animal Vaccines, by Animal Species, Through 2028
  • Table 38 : Bayer's Production Animal Vaccines, by Target Species
  • Table 39 : Boehringer Ingelheim's Production Animal Vaccines, by Target Species
  • Table 40 : Elanco's Production Animal Vaccines, by Target Species
  • Table 41 : Merck's Production Animal Vaccines, by Target Species
  • Table 42 : Zoetis' Production Animal Vaccines, by Target Species
  • Table 43 : Global Market for Animal Pharmaceuticals, by Type, Through 2028
  • Table 44 : Global Market for Animal Pharmaceuticals, by Animal Group, Through 2028
  • Table 45 : Global Market for Animal Pharmaceuticals, by Region, Through 2028
  • Table 46 : Boehringer Ingelheim's Allergy and Respiratory Drugs, by Target Species
  • Table 47 : Dechra Pharmaceuticals' Allergy and Respiratory Drugs, by Target Species
  • Table 48 : Elanco's Allergy and Respiratory Drugs, by Target Species
  • Table 49 : Heska's Allergy and Respiratory Drugs, by Target Species
  • Table 50 : Huvepharma's Allergy and Respiratory Drugs, by Target Species
  • Table 51 : Virbac's Allergy and Respiratory Drugs, by Target Species
  • Table 52 : Zoetis' Allergy and Respiratory Drugs, by Target Species
  • Table 53 : Global Market for Allergy and Respiratory Drugs, by Animal Group, Through 2028
  • Table 54 : Bayer's Anti-infective Drugs, by Target Species
  • Table 55 : Boehringer Ingelheim's Anti-infective Drugs, by Target Species
  • Table 56 : Dechra Pharmaceuticals' Anti-infective Drugs, by Target Species
  • Table 57 : ECO Animal Health's Anti-infective Drugs, by Target Species
  • Table 58 : Elanco's Anti-infective Drugs, by Target Species
  • Table 59 : Merck's Anti-infective Drugs, by Target Species
  • Table 60 : Virbac's Anti-infective Drugs, by Target Species
  • Table 61 : Zoetis' Anti-infective Drugs, by Target Species
  • Table 62 : Global Market for Anti-infectives, by Animal Group, Through 2028
  • Table 63 : Aratana Therapeutics' Anti-inflammatories and Analgesics, by Target Species
  • Table 64 : Bayer Anti-inflammatories and Analgesics, by Target Species
  • Table 65 : Boehringer Ingelheim's Anti-inflammatories and Analgesics, by Target Species
  • Table 66 : Dechra Pharmaceuticals' Anti-inflammatories and Analgesics, by Target Species
  • Table 67 : Elanco's Anti-inflammatories and Analgesics, by Target Species
  • Table 68 : Merck's Anti-inflammatories and Analgesics, by Target Species
  • Table 69 : Vetoquinol's Anti-inflammatories and Analgesics, by Target Species
  • Table 70 : Zoetis' Anti-inflammatories and Analgesics, by Target Species
  • Table 71 : Global Market for Anti-inflammatories and Analgesics, by Animal Group, Through 2028
  • Table 72 : Aratana Therapeutics' Metabolic and Endocrine Drugs, by Target Species
  • Table 73 : Bayer's Metabolic and Endocrine Drugs, by Target Species
  • Table 74 : Boehringer Ingelheim's Metabolic and Endocrine Drugs, by Target Species
  • Table 75 : Dechra Pharmaceuticals' Metabolic and Endocrine Drugs, by Target Species
  • Table 76 : Merck's Metabolic and Endocrine Drugs, by Target Species
  • Table 77 : Virbac's Metabolic and Endocrine Drugs, by Target Species
  • Table 78 : Zoetis' Metabolic and Endocrine Drugs, by Target Species
  • Table 79 : Global Market for Metabolic Drugs, by Animal Group, Through 2028
  • Table 80 : Bayer's Parasiticides, by Target Species
  • Table 81 : Beaphar's Parasiticides, by Target Species
  • Table 82 : Boehringer Ingelheim's Parasiticides, by Target Species
  • Table 83 : ECO Animal Health's Parasiticides, by Target Species
  • Table 84 : Elanco's Parasiticides, by Target Species
  • Table 85 : Huvepharma Parasiticides, by Target Species
  • Table 86 : Merck's Parasiticides, by Target Species
  • Table 87 : Virbac's Parasiticides, by Target Species
  • Table 88 : Zoetis' Parasiticides, by Target Species
  • Table 89 : Global Market for Parasiticides, by Animal Group, Through 2028
  • Table 90 : Boehringer Ingelheim's Psychotropic Medications, by Target Species
  • Table 91 : Elanco's Psychotropic Medications, by Target Species
  • Table 92 : Vetoquinol's Psychotropic Medications, by Target Species
  • Table 93 : Zoetis' Psychotropic Medications, by Target Species
  • Table 94 : Bayer's Other Pharmaceuticals, by Target Species
  • Table 95 : Boehringer Ingelheim's Other Pharmaceuticals, by Target Species
  • Table 96 : Dechra Pharmaceuticals' Other Pharmaceuticals, by Target Species
  • Table 97 : Elanco's Other Pharmaceuticals, by Target Species
  • Table 98 : HbO2 Therapeutics' Other Pharmaceuticals, by Target Species
  • Table 99 : Merck's Other Pharmaceuticals, by Target Species
  • Table 100 : Virbac's Other Pharmaceuticals, by Target Species
  • Table 101 : Vetoquinol's Other Pharmaceuticals, by Target Species
  • Table 102 : Zoetis' Other Pharmaceuticals, by Target Species
  • Table 103 : Dental Pharmaceuticals, by Target Species and Provider
  • Table 104 : Global Market for Other Pharmaceuticals, by Animal Group, Through 2028
  • Table 105 : Global Market for Animal Feed Additive Products, by Type, Through 2028
  • Table 106 : Global Market for Feed Additives, by Animal Group, Through 2028
  • Table 107 : Global Market for Animal Feed Additives, by Region, Through 2028
  • Table 108 : Adisseo's Amino Acids, by Target Species
  • Table 109 : Ajinomoto's Amino Acids, by Target Species
  • Table 110 : Boehringer Ingelheim's Amino Acids, by Target Species
  • Table 111 : Evonik's Amino Acids, by Target Species
  • Table 112 : Global Market for Amino Acids, by Animal Group, Through 2028
  • Table 113 : Dechra Pharmaceuticals' Medicinal Additives, by Target Species
  • Table 114 : ECO Animal Health Medicinal Additives, by Target Species
  • Table 115 : Elanco's Medicinal Additives, by Target Species
  • Table 116 : Huvepharma's Medicinal Additives, by Target Species
  • Table 117 : Merck's Medicinal Additives, by Target Species
  • Table 118 : Phibro's Medicinal Additives, by Target Species
  • Table 119 : Zoetis' Medicinal Additives, by Target Species
  • Table 120 : Global Market for Medicinal Feed Additives, by Animal Group, Through 2028
  • Table 121 : Adisseo (Bluestar) Nutritional Supplements, by Target Species
  • Table 122 : Bayer's Nutritional Supplements, by Target Species
  • Table 123 : BASF's Nutritional Supplements, by Target Species
  • Table 124 : Beaphar's Nutritional Supplements, by Target Species
  • Table 125 : Boehringer Ingelheim's Nutritional Supplements, by Target Species
  • Table 126 : Dechra Pharmaceuticals' Nutritional Supplements, by Target Species
  • Table 127 : DSM's Nutritional Supplements, by Target Species
  • Table 128 : Elanco's Nutritional Supplements, by Target Species
  • Table 129 : Evonik's Nutritional Supplements, by Target Species
  • Table 130 : Heska's Nutritional Supplements, by Target Species
  • Table 131 : Mosaic's Nutritional Supplements, by Target Species
  • Table 132 : Vetoquinol's Nutritional Supplements, by Target Species
  • Table 133 : Virbac's Nutritional Supplements, by Target Species
  • Table 134 : Global Market for Nutritional Supplements, by Animal Group, Through 2028
  • Table 135 : Adisseo's Vitamins and Minerals, by Target Species
  • Table 136 : BASF's Vitamins and Minerals, by Target Species
  • Table 137 : Bayer's Vitamins and Minerals, by Target Species
  • Table 138 : Beaphar's Vitamins and Minerals, by Target Species
  • Table 139 : DSM's Vitamins and Minerals, by Target Species
  • Table 140 : Merck's Vitamins and Minerals, by Target Species
  • Table 141 : Zoetis' Vitamins and Minerals, by Target Species
  • Table 142 : Global Market for Vitamins and Minerals, by Animal Group, Through 2028
  • Table 143 : Global Market for Animal Diagnostics, by Type, Through 2028
  • Table 144 : Global Market for Animal Diagnostic Products, by Animal Group, Through 2028
  • Table 145 : Global Market for Animal Diagnostics, by Region, Through 2028
  • Table 146 : Bayer's Diagnostics, by Target Species
  • Table 147 : Beaphar's Diagnostics, by Target Species
  • Table 148 : Elanco's Diagnostics, by Target Species
  • Table 149 : Heska's Diagnostics, by Target Species
  • Table 150 : IDEXX's Diagnostics, by Target Species
  • Table 151 : Merck's Diagnostics, by Target Species
  • Table 152 : Virbac's Diagnostics, by Target Species
  • Table 153 : Zoetis' Diagnostics, by Target Species
  • Table 154 : Global Market for Rapid Diagnostics Tests, by Animal Group, Through 2028
  • Table 155 : Global Market for Diagnostic Analyzers and Consumables, by Animal Group, Through 2028
  • Table 156 : Global Market for Diagnostic Imaging Equipment and Related Materials, by Animal Group, Through 2028
  • Table 157 : Global Market for Animal Therapeutics and Diagnostics, by Region, Through 2028
  • Table 158 : ESG Ratings and Metrics
  • Table 159 : Environmental Performance: Animal Therapeutics and Diagnostics Industry
  • Table 160 : Social Performance: Animal Therapeutics and Diagnostics Industry
  • Table 161 : Governance Performance: Animal Therapeutics and Diagnostics Industry
  • Table 162 : ESG Rankings for Major Animal Therapeutics and Diagnostics Companies, March 2023
  • Table 163 : M&A in the Animal Healthcare Industry, 2021
  • Table 164 : Mergers & Acquisitions: Market for Animal Therapeutics and Diagnostics, August 2020-December 2022
  • Table 165 : New Product Launches: Market for Animal Therapeutics and Diagnostics, March 2022-November 2022
  • Table 166 : Partnerships: Market for Animal Therapeutics and Diagnostics, March 2021-March 2023
  • Table 167 : Partnerships: Market for Animal Therapeutics and Diagnostics, March 2021-March 2023
  • Table 168 : Others: Market for Animal Therapeutics and Diagnostics, November 2021-June 2023
  • Table 169 : ARKO Laboratories: Animal Health Products
  • Table 170 : Avimex: Animal Vaccine Products
  • Table 171 : Avimex: News, 2021
  • Table 172 : Boehringer Ingelheim: Key Financials, 2022
  • Table 173 : Boehringer Ingelheim: News, 2022 and 2023
  • Table 174 : Boehringer Ingelheim: Animal Health Products
  • Table 175 : Ceva: Key Financials, 2022
  • Table 176 : Ceva: News, 2022 and 2023
  • Table 177 : Ceva: Animal Health Products
  • Table 178 : Dechra: Key Financials, 2022
  • Table 179 : Dechra: News, 2021-2023
  • Table 180 : Dechra: Animal Health Products
  • Table 181 : DSM Nutritional Products: Key Financials, 2022
  • Table 182 : DSM Nutritional Products: News, 2022
  • Table 183 : DSM Nutritional Products Ltd: Animal Health Products
  • Table 184 : Elanco: Key Financials, 2022
  • Table 185 : Elanco: News, 2020-2023
  • Table 186 : Elanco: Animal Health Products
  • Table 187 : Merck & Co. Inc.: Key Financials, 2022
  • Table 188 : Merck & Co. Inc.: News, 2022
  • Table 189 : Merck & Co. Inc.: Animal Health Products
  • Table 190 : Phibro Animal Health Corp.: Key Financials, 2022
  • Table 191 : Phibro Animal Health Corp.: News, 2022
  • Table 192 : Phibro Animal Health Corp.: Animal Vaccine Products
  • Table 193 : Virbac S.A.: Key Financials, 2022
  • Table 194 : Virbac S.A.: News, 2021 and 2022
  • Table 195 : Virbac S.A.: Animal Vaccine Products
  • Table 196 : Zoetis Services LLC: Key Financials, 2022
  • Table 197 : Zoetis Services LLC: News, 2021-2023
  • Table 198 : Zoetis Services LLC : Animal Vaccine Products

List of Figures

  • Summary Figure : Global Market for Animal Therapeutics and Diagnostics, by Product Type, 2020-2028
  • Figure 1 : Number of Countries Affected by HPAI, 2005-2021
  • Figure 2 : Modalities for Purchasing Rabies Vaccine from World Vaccine Bank, 2012-2021
  • Figure 3 : Worldwide Distribution of SARS-CoV-2 Outbreaks in 23 Animal Species
  • Figure 4 : Global Market for Animal Therapeutics and Diagnostics, by Product Segment, 2020-2028
  • Figure 5 : Global Market for Animal Therapeutics and Diagnostics, by Animal Group, 2020-2028
  • Figure 6 : Global Market for Animal Therapeutics and Diagnostics, by Region, 2020-2028
  • Figure 7 : Global Market for Animal Vaccines, by Animal Group, 2020-2028
  • Figure 8 : Global Market for Animal Vaccines, by Region, 2020-2028
  • Figure 9 : Global Market Shares of Animal Vaccines, by Region, 2023
  • Figure 10 : Global Market for Companion Animal Vaccines, by Animal Species, 2020-2028
  • Figure 11 : Global Market for Companion Animal Vaccines, by Type, 2020-2028
  • Figure 12 : Global Market for Production Animal Vaccines, by Animal Species, 2020-2028
  • Figure 13 : Global Market for Production Animal Vaccines, by Type, 2020-2028
  • Figure 14 : Global Market for Animal Pharmaceuticals, by Type, 2020-2028
  • Figure 15 : Global Market Shares of Animal Pharmaceuticals, by Animal Group, 2023
  • Figure 16 : Global Market Shares of Animal Pharmaceuticals, by Region, 2023
  • Figure 17 : Global Market for Allergy and Respiratory Drugs, by Animal Group, 2020-2028
  • Figure 18 : Global Market for Anti-infectives, by Animal Group, 2020-2028
  • Figure 19 : Global Market for Anti-inflammatories and Analgesics, by Animal Group, 2020-2028
  • Figure 20 : Global Market for Metabolic Drugs, by Animal Group, 2020-2028
  • Figure 21 : Global Market for Parasiticides, by Animal Group, 2020-2028
  • Figure 22 : Global Market for Other Pharmaceuticals, by Animal Group, 2020-2028
  • Figure 23 : Global Market for Animal Feed Additive Products, by Type, 2020-2028
  • Figure 24 : Global Market Shares of Feed Additives, by Animal Group, 2023
  • Figure 25 : Global Market Shares of Animal Feed Additives, by Region, 2023
  • Figure 26 : Global Market for Amino Acids, by Animal Group, 2020-2028
  • Figure 27 : Global Market for Medicinal Feed Additives, by Animal Group, 2020-2028
  • Figure 28 : Global Market for Nutritional Supplements, by Animal Group, 2020-2028
  • Figure 29 : Global Market for Vitamins and Minerals, by Animal Group, 2020-2028
  • Figure 30 : Global Market for Animal Diagnostics, by Type, 2020-2028
  • Figure 31 : Global Market Shares of Animal Diagnostics, by Animal Group, 2023
  • Figure 32 : Global Market Shares of Animal Diagnostics, by Region, 2023
  • Figure 33 : Global Market for Rapid Diagnostic Tests, by Animal Group, 2020-2028
  • Figure 34 : Global Market for Rapid Diagnostics, by Test Type (Veterinary Applications), 2020-2028
  • Figure 35 : Global Market for Diagnostic Analyzers and Consumables, by Animal Group, 2020-2028
  • Figure 36 : Global Market for Diagnostic Analyzers and Consumables, by Test Type (Veterinary Applications), 2020-2028
  • Figure 37 : Global Market for Diagnostic Imaging Equipment and Related Materials, by Animal Group, 2020-2028
  • Figure 38 : Global Market Shares of Animal Therapeutics and Diagnostics, by Region, 2023
  • Figure 39 : North American Beef Cattle Inventory, 2000-2022
  • Figure 40 : North American Market for Animal Therapeutics and Diagnostics, by Product Type, 2020-2028
  • Figure 41 : European Market for Animal Therapeutics and Diagnostics, by Product Type, 2020-2028
  • Figure 42 : Asia-Pacific Market for Animal Therapeutics and Diagnostics, by Product Type, 2020-2028
  • Figure 43 : Rest of the World Market for Animal Therapeutics and Diagnostics, by Product Type, 2022-2028
  • Figure 44 : How A Strong ESG Proposition Benefits Businesses
  • Figure 45 : The Ten Business Sustainability Trends Identified for 2022
  • Figure 46 : Top Animal Health Mergers and Acquisitions Worldwide, 2014-2018, by Enterprise Value
  • Figure 47 : Animal Healthcare Industry: M & A Deals, 2019-2021
  • Figure 48 : Leading Market Players' Animal Health Revenue, 2022
  • Figure 49 : Global Market Shares of Animal Therapeutics and Diagnostics: Competitive Intelligence, 2020 to 2023
  • Figure 50 : Boehringer Ingelheim: Key Financials, 2021 and 2022
  • Figure 51 : Boehringer Ingelheim: Revenue Share, by Business Unit, 2022
  • Figure 52 : Boehringer Ingelheim: Revenue Share, by Region, 2022
  • Figure 53 : Ceva: Key Financials, 2021 and 2022
  • Figure 54 : Dechra: Key Financials, 2021 and 2022
  • Figure 55 : Dechra: Revenue Share, by Business Unit, 2022
  • Figure 56 : Dechra: Revenue Share, by Region, 2022
  • Figure 57 : DSM Nutritional Products: Key Financials, 2021 and 2022
  • Figure 58 : DSM Nutritional Products Ltd: Revenue Share, by Business Unit, 2022
  • Figure 59 : DSM Nutritional Products Ltd: Revenue Share, by Country/Region, 2022
  • Figure 60 : Elanco: Key Financials, 2021 and 2022
  • Figure 61 : Elanco: Revenue Share, by Business Unit, 2022
  • Figure 62 : Elanco: Revenue Share, by Country/Region, 2022
  • Figure 63 : Merck & Co. Inc.: Key Financials, 2021 and 2022
  • Figure 64 : Merck & Co. Inc.: Revenue Share, by Business Unit, 2022
  • Figure 65 : Merck & Co. Inc.: Revenue Share, by Country/Region, 2022
  • Figure 66 : Phibro Animal Health Corp.: Key Financials, 2021 and 2022
  • Figure 67 : Phibro Animal Health Corp.: Revenue Share, by Business Unit, 2022
  • Figure 68 : Phibro Animal Health Corp.: Revenue Share, by Country/Region, 2022
  • Figure 69 : Virbac S.A.: Key Financials, 2021 and 2022
  • Figure 70 : Virbac S.A.: Revenue Share, by Business Unit, 2022
  • Figure 71 : Zoetis Services LLC: Key Financials, 2021 and 2022
  • Figure 72 : Zoetis Services LLC : Revenue Share, by Business Unit, 2022
  • Figure 73 : Zoetis Services LLC: Revenue Share, by Country/Region, 2022